Diagnostics Solutions Strategic Priorities

Example: Our comprehensive solution for lung cancer Innovating clinical decision making and improving patient care Roche IA Diagnosis & Classification IHC PCR IHC XX Therapy selection ProGRP Napsin A, TTF1, CK5/6, p63, p40, ROS1, pan-TRK EGFR, KRAS, BRAF ALK, PD-L1 PD-L1 Algorithm Monitoring/Surveillance NGS IA PCR JVVV Foundation One CDx Decision Support: NAVIFY Tumor Board, NAVIFY Mutation Profiler M CYFRA 21-1, ProGRP, NSE, SCC EGFR 66

View entire presentation